Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support

Journal of Hematotherapy and Stem Cell Research

Volumn 6, Issue 1, 1997, Pages 61-68

  Papadopoulos, K P ^a   Ayello, J ^a   Tugulea, S ^a   Heitjan, D F ^b   Williams, C ^a   Reiss, R F ^a   Vahdat, L T ^a   Suciu Foca, N ^a   Antman, K H ^a   Hesdorffer, C S ^a,c  

^a The New York Presbyterian Hospital   (United States)

^b School of Public Health ^*  (United States)

^c Division of Medical Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA;

ADULT; ARTICLE; AUTOTRANSPLANTATION; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CELL ISOLATION; CELL SELECTION; CELL TRANSPLANTATION; CLINICAL ARTICLE; COLONY FORMING UNIT GM; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; LEUKAPHERESIS; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD; ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; BONE MARROW PURGING; BREAST NEOPLASMS; CARBOPLATIN; COLONY-FORMING UNITS ASSAY; CYCLOPHOSPHAMIDE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LENGTH OF STAY; MIDDLE AGED; NEOPLASM STAGING; PLATELET COUNT; REGRESSION ANALYSIS; RISK ASSESSMENT; THIOTEPA;

EID: 0030987147     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1997.6.61     Document Type: Article

References (32)

1. Antman, K., Armitage, J., Horowitz, M., et al. Autotransplants for breast cancer in North America, Proc. Am. Soc. Clin. Oncol. 13:67 (abstract), 1994.
2. To, L.B., Haylock, D.N., Dowse, T., et al. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells. Blood 84:2930, 1994.
3. Bender, J.G., Williams, S.F., Myers, S., et al. Characterization of chemotherapy mobilized peripheral blood progenitor cells for use in autologous stem cell transplantation. Bone Marrow Transplant. 10:281, 1992.
4. Henon, P.R., Liang, H., Beck-Wirth, G., et al. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant. 9:285, 1992.
5. Sheridan, W.P., Begley, C.G., Juttner, C.A., et al. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640, 1992.
6. Elias, A., Ayash, L., Anderson, K., et al. Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 79:3036, 1992.
7. Antman, K., Ayash, L., Elias, A., et al. A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard dose therapy. J. Clin. Oncol. 10:102, 1992.
8. Vahdat, L. & Antman, K. High-dose therapy for breast cancer. Blood Rev. 9:199, 1995.
9. Ayello, J., Hesdorffer, C. & Reiss, R. A semiautomated technique for volume reduction of stem cell suspensions for autotransplanation. J. Hematother. 4:545, 1995.
10. Holyoake, T.L. & Alcorn, M.J. CD34+ positive haemopoietic cells: Biology and clinical applications. Blood Rev. 8:113, 1994.
11. Fritsch, G., Emminger, W., Buchinger, P., et al. CD34-positive cell proportions in peripheral blood correlate with colony-forming capacity. Exp. Hematol. 19:1079, 1991.
12. Siena, S., Bregni, M., Brando, B., et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77:400, 1991.
13. Teixeira, G., Lenormand, B., Jean, P., et al. Immunological evaluation of harvested stem cells obtained by leukapheresis after chemotherapy. Am. J. Hematol. 39:172, 1992.
14. van der Wall, E., Richel, D.J., Holtkamp, M.J., et al. Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: Effect of graft size. Ann. Oncol. 5:795, 1994.
15. Ho, A.D., Gluck, S., Germond, C., et al. Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte-macrophage colony-stimulating factor for autologous transplantation in advanced breast cancer. Leukemia 7:1738, 1993.
16. Schwartzberg, L., Birch, R., Blanco, R., et al. Rapid and sustained hematopoietic reconstitution by peripheral blood stem cell infusion alone following high-dose chemotherapy. Bone Marrow Transplant. 11:369, 1993.
17. Bender, J.G., Lum, L., Unverzagt, K.L., et al. Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens. Bone Marrow Transplant. 13:479, 1994.
18. Zimmerman, T., Lee, W., Bender, J., et al. Quantitative CD34 analysis may be used to guide peripheral blood stem cell harvests. Bone Marrow Transplant. 9:439, 1995.
19. Chabannon, C., Le Coroller, A., Faucher, C., et al. Patient condition affects the collection of peripheral blood progenitors after priming with recombinant granulocyte colony-stimulating factor. J. Hematother. 4:171, 1995.
20. Janssen, W.E. Farmelo, M.J., Lee, C., et al. The CD34+ cell fraction in bone marrow and blood is not universally predictive of CFU-GM. Exp. Hematol. 20:528, 1992.
21. Bensinger, W.I., Longin, K., Appelbaum, F., et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony-stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation. Br. J. Haematol. 87:825, 1994.
22. Haas, R., Mohle, R., Murea, S., et al. Characterization of peripheral blood progenitor cells mobilized by cytotoxic chemotherapy and recombinant human granulocyte colony-stimulating factor. J. Hematother. 3:323, 1994.
23. Freuhauf, S., Haas, R., Conradt, C., et al. Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported bytotoxic chemotherapy. Blood 85:2619, 1995.
24. Elliott, C., Samson, D.M., Armitage, S., et al. When to harvest peripheral-blood stem cells after mobilization therapy: Prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood. J. Clin. Oncol. 14:970, 1996.
25. Bensinger, W., Appelbaum, F., Rowley, S., et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J. Clin. Oncol. 13:2547, 1995.
26. Kotasek, D., Shepherd, K.M., Sage, R.E., et al. Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant. 9:11, 1992.
27. Peters, W., Ross, M., Vredenburgh, J., et al. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J. Clin. Oncol. 11:1132, 1993.
28. van der Wall, E., Nooijen, W.J., Baars, J.W., et al. High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: A practical approach. Br. J. Cancer 71:857, 1995.
29. Pettengell, R., Morgenstern, G.R., Woll, P.J., et al. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 82:3770, 1993.
30. Greenberger, J. Toxic effects on the hematopoietic microenvironment. Exp. Hematol. 19:1101, 1991.
31. Comenzo, R.L., Vosburgh, E., Weintraub, L.R., et al. Collection of mobilized blood progenitor cells for hematopoietic rescue by large-volum leukapheresis. Transfusion 35:493, 1995.
32. Passos-Coelho, J.L., Braine, H.G., Davis, J.M., et al. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. J. Clin. Oncol. 13:705, 1995.